These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 33836742)

  • 1. Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development.
    Kremer IEH; Jongen PJ; Evers SMAA; Hoogervorst ELJ; Verhagen WIM; Hiligsmann M
    BMC Med Inform Decis Mak; 2021 Apr; 21(1):123. PubMed ID: 33836742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients.
    Bansback N; Chiu JA; Carruthers R; Metcalfe R; Lapointe E; Schabas A; Lenzen M; Lynd LD; Traboulsee A
    BMC Neurol; 2019 Jul; 19(1):173. PubMed ID: 31325961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of preferences of healthcare professionals and MS patients for attributes of disease-modifying drugs: A best-worst scaling.
    Kremer IEH; Evers SMAA; Jongen PJ; Hiligsmann M
    Health Expect; 2018 Feb; 21(1):171-180. PubMed ID: 28734004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit-risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis.
    Vermersch P; Martinelli V; Pfleger C; Rieckmann P; Alonso-Magdalena L; Galazka A; Dangond F; Phillips L
    Clin Ther; 2019 Feb; 41(2):249-260.e18. PubMed ID: 30846120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplifying Each Patient's Voice: A Systematic Review of Multi-criteria Decision Analyses Involving Patients.
    Marsh K; Caro JJ; Hamed A; Zaiser E
    Appl Health Econ Health Policy; 2017 Apr; 15(2):155-162. PubMed ID: 27928659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing Shared Decision-Making for Multiple Sclerosis: The MS-SUPPORT Tool.
    Col NF; Solomon AJ; Alvarez E; Pbert L; Ionete C; BerriosMorales I; Chester J; Kutz C; Iwuchukwu C; Livingston T; Springmann V; Col HV; Ngo LH
    Mult Scler Relat Disord; 2023 Dec; 80():105092. PubMed ID: 37931489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis patients' understanding and preferences for risks and benefits of disease-modifying drugs: A systematic review.
    Reen GK; Silber E; Langdon DW
    J Neurol Sci; 2017 Apr; 375():107-122. PubMed ID: 28320112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Views of Multiple Sclerosis Patients About Key Elements for a Decision Aid: A Qualitative Study.
    Robles-Sanchez MA; Moharra M; Bosch-Farré C; Hernández-Leal MJ; Montalban X; Sastre-Garriga J; Ramió-Torrentà L; Bertran-Noguer C
    J Neurosci Nurs; 2023 Oct; 55(5):164-170. PubMed ID: 37527935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
    Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
    Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - Feasibility testing, pilot randomised controlled trial and mixed methods process evaluation.
    Rahn AC; Köpke S; Backhus I; Kasper J; Anger K; Untiedt B; Alegiani A; Kleiter I; Mühlhauser I; Heesen C
    Int J Nurs Stud; 2018 Feb; 78():26-36. PubMed ID: 28982479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Cost Effectiveness of Shared Decision Making for Choosing between Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis in the Netherlands: A State Transition Model.
    Kremer IEH; Hiligsmann M; Carlson J; Zimmermann M; Jongen PJ; Evers SMAA; Petersohn S; Pouwels XGLV; Bansback N
    Med Decis Making; 2020 Nov; 40(8):1003-1019. PubMed ID: 33174513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA).
    Villanueva V; Carreño M; Gil-Nagel A; Serrano-Castro PJ; Serratosa JM; Toledo M; Álvarez-Barón E; Gil A; Subías-Labazuy S
    Epilepsy Behav; 2021 Sep; 122():108222. PubMed ID: 34371462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut).
    Guarga L; Badia X; Obach M; Fontanet M; Prat A; Vallano A; Torrent J; Pontes C
    Orphanet J Rare Dis; 2019 Jun; 14(1):157. PubMed ID: 31248421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Users of Healthcare Services: Development and Alpha Testing of a Patient Decision Aid for Case Management.
    Poitras ME; Légaré F; Tremblay Vaillancourt V; Godbout I; Poirier A; Prévost K; Spence C; Chouinard MC; Zomahoun HTV; Khadhraoui L; Massougbodji J; Bujold M; Pluye P; Hudon C
    Patient; 2020 Dec; 13(6):757-766. PubMed ID: 33083997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. User-Centered Development of a Patient Decision Aid for Choice of Early Abortion Method: Multi-Cycle Mixed Methods Study.
    Wahl KJ; Brooks M; Trenaman L; Desjardins-Lorimer K; Bell CM; Chokmorova N; Segall R; Syring J; Williams A; Li LC; Norman WV; Munro S
    J Med Internet Res; 2024 Apr; 26():e48793. PubMed ID: 38625731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial User Testing of Decision Aids for Multiple Sclerosis Disease-Modifying Therapies.
    Hakim H; Newland P; Oliver BJ
    J Neurosci Nurs; 2020 Aug; 52(4):160-165. PubMed ID: 32511174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-Designing a Consult Patient Decision Aid for Continuation Versus Deprescribing Cholinesterase Inhibitors in People Living with Dementia.
    Ailabouni NJ; Thompson W; Hilmer SN; Quirke L; McNeece J; Bourke A; Furst C; Reeve E
    Drugs Aging; 2024 Oct; 41(10):821-831. PubMed ID: 39289289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision aid prototype development for parents considering adenotonsillectomy for their children with sleep disordered breathing.
    Maguire E; Hong P; Ritchie K; Meier J; Archibald K; Chorney J
    J Otolaryngol Head Neck Surg; 2016 Nov; 45(1):57. PubMed ID: 27809897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "Begin Exploring Fertility Options, Risks and Expectations" (BEFORE) decision aid: development and alpha testing of a fertility tool for premenopausal breast cancer patients.
    Speller B; Metcalfe K; Kennedy ED; Facey M; Greenblatt E; Scheer AS; Warner E; Joy AA; Wright FC; Baxter NN
    BMC Med Inform Decis Mak; 2019 Oct; 19(1):203. PubMed ID: 31660965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PATIENT-CENTERED DECISION MAKING: LESSONS FROM MULTI-CRITERIA DECISION ANALYSIS FOR QUANTIFYING PATIENT PREFERENCES.
    Marsh K; Caro JJ; Zaiser E; Heywood J; Hamed A
    Int J Technol Assess Health Care; 2018 Jan; 34(1):105-110. PubMed ID: 29277175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.